About BigHat Biosciences
BigHat Biosciences is a novel protein therapeutics company and developer of an AI-guided antibody design platform
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- San Mateo, California
- Founded
- 2019
- Company type
- Privately Held
BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.
BigHat is backed by Section 32, Andreessen Horowitz, 8VC, Amgen Ventures, Bristol Myers Squibb, Quadrille, Grids Capital, AME Cloud Ventures, Innovation Endeavors and Gaingels.
Company locations
1900 Alameda de Las Pulgas, San Mateo, California 94403, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
Business areas
- Artificial Intelligence
- Biotechnology
- Medical
- Artificial Intelligence (AI)
- Therapeutics
On LinkedIn
- Followers
- 12,534
- People linked to this company
- 95
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
99,302,511 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.